Key Dates

Related Announcements

PAR-21-295 - NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)

NOT-CA-22-137 - Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-21-295 “NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)”

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to clarify the eligibility of Program Directors/Principal Investigators (PDs/PIs) in Funding Opportunity Announcement (FOA) PAR-21-295, “NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed). This Notice replaces and rescinds NOT-CA-22-137.

The following section of the FOA is revised accordingly:

Part 2. Section III. Eligibility Information

Eligible Individuals (Program Director/Principal Investigator)

Enhancing Diversity:

Currently Reads:

For purposes of this funding opportunity announcement, individuals from categories A and B of the Notice of NIH’s Interest in Diversity are particularly encouraged to apply for support under this program.

Modified to Read (changes highlighted in bold italics):

For purposes of this funding opportunity announcement, individuals from diverse backgrounds, including the categories listed in Notice of NIH’s Interest in Diversity are encouraged to apply for support under this program.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Behrous Davani, PhD
National Cancer Institute (NCI)
Telephone: 240-276-6170
Email: [email protected]